Fluticasone

Fluticasone: Patient Information for Australia

Basic Product Information

Mechanism of Action

For patients: Fluticasone is a type of corticosteroid (sometimes called “steroid”). It helps reduce inflammation in your airways and nasal passages. This makes breathing easier and reduces symptoms like wheezing, runny or blocked nose, and sneezing.

For specialists: Fluticasone propionate and furoate are synthetic trifluorinated corticosteroids that act locally by inhibiting multiple cell types (mast cells, eosinophils, macrophages) and mediators (histamines, cytokines) involved in the inflammatory response. They bind with high affinity to the human glucocorticoid receptor, modulating gene transcription and decreasing pro-inflammatory proteins.

Pharmacokinetics

• Absorption: Systemic absorption is low when inhaled or sprayed nasally; oral bioavailability is <1% due to extensive first-pass metabolism in the liver.
• Metabolism: Rapidly metabolised in the liver by CYP3A4 to inactive metabolites.
• Elimination: Mainly excreted in faeces; terminal half-life after inhalation is 7–8 hours.
• Duration of Action: Effects may last up to 24 hours with regular use.

Use in Everyday Life and Best Practices in Australia

Fluticasone is prescribed in Australia mostly for managing asthma, chronic obstructive pulmonary disease (COPD), and as a nasal spray for allergic or non-allergic rhinitis. Sometimes it is also used (as a cream or ointment) for certain skin rashes. It is essential to use fluticasone exactly as directed by your doctor or pharmacist.

• Inhalers (for asthma/COPD):
  • Shake the inhaler (unless a dry powder inhaler), breathe out gently, seal lips around the mouthpiece, and press/puff while inhaling deeply.
  • Rinse mouth with water and spit out after each use to reduce risk of oral thrush.
  • Common adult maintenance dose: 100–500 mcg once or twice daily.
• Nasal Spray (for allergies):
  • Prime before first use, gently blow nose, spray into nostril while breathing in gently, and avoid tilting head back.
  • Usual dose: 1–2 sprays into each nostril once or twice daily.
• Topical (skin):
  • Apply in a thin layer to the affected area once or twice daily.

Storage: Store in a cool, dry place below 30°C; protect from direct sunlight. Always check expiry dates and return expired inhalers or sprays to your pharmacy for safe disposal.

Dosing in the Morning vs. Evening

• Morning use: May help establish a routine; aligns with Australian school and work schedules.
• Evening use: Can relieve night-time symptoms (particularly helpful if symptoms worsen at night).
• Tips: For maximum benefit, take fluticasone at the same time every day, whether in the morning or evening. Set alarms or pair with regular habits (e.g., brushing teeth).
• Discuss and decide timing with your GP, especially if you notice symptoms varying during the day.

Taking With Food or On an Empty Stomach

• Fluticasone inhalers and nasal sprays: There is no need to take with food—meals do not affect their absorption or effectiveness. You can take your dose before or after meals, as convenient.
• Topical fluticasone: Dietary factors do not affect absorption via the skin.
• Oral versions (rare in AU): If prescribed for special circumstances, follow your doctor’s instructions on meals, due to potential for more side effects.
• No specific dietary restrictions are needed for typical English/Australian diets.

Interaction Warnings

Indications

Dosing According to Clinical Indications

Always check with your pharmacist or doctor for individualised advice.

Safety Profile and Side Effects

Fluticasone is well tolerated when used as directed. Side effects depend on the route of administration and dose.

• Do not stop fluticasone suddenly if used for weeks or more – discuss with your doctor.
• Notify your doctor of new symptoms, persistent infections, or unexplained tiredness.

Guidelines for Proper Use

1. Use fluticasone at the same time(s) each day.
2. Follow the device instructions carefully—ask your pharmacist to demonstrate correct inhaler or spray technique.
3. Keep inhaler devices clean (wipe mouthpiece weekly).
4. Record doses on a calendar or app to maintain supply.
5. Do not share your medicine with others.
6. In case of missed dose: take as soon as remembered if within a few hours, otherwise skip and continue as scheduled.
7. If you have scheduled vaccinations or are travelling overseas, discuss your corticosteroid use with your doctor.
8. During asthma “flare-ups” or severe allergy season, your GP may adjust your dose temporarily.
9. In the case of recurring side effects, report promptly for possible alternative therapy or dose adjustment.

Alternative Treatment Options

• Other inhaled corticosteroids (ICS): Budesonide (Pulmicort®), beclometasone (Qvar®)—similar efficacy, different inhaler devices and dosing frequencies.
• Leukotriene receptor antagonists: Montelukast (Singulair®); oral use, especially in children and allergic rhinitis, but less effective for severe asthma.
• Combined Inhalers: Seretide® (fluticasone/salmeterol), Symbicort® (budesonide/formoterol), Flutiform® (fluticasone/formoterol).
• Oral antihistamines for allergies: Cetirizine, loratadine, fexofenadine—for mild symptoms.
• Most of these alternatives are subsidised under the PBS (Pharmaceutical Benefits Scheme).

Decisions should be tailored to your clinical history and preferences.

Legal, Registration, and Reimbursement Status in Australia

• Regulated by the Therapeutic Goods Administration (TGA) as a Schedule 4 medicine (requires prescription).
• Fluticasone is registered for the treatment of asthma, COPD, allergic and non-allergic rhinitis, and certain dermatoses.
• Multiple brands are listed on the PBS for asthma, chronic asthma, and chronic rhinitis, subsidised for eligible patients upon prescription.
• Pharmacists must confirm new scripts and patient identity as per national regulations.

Latest Research & Clinical Guidance (2022–2025)

• GINA Guidelines 2024: Recommend inhaled corticosteroids (including fluticasone) as the cornerstone of persistent asthma management, with combination inhaled therapy for moderate-severe cases.
• COPD-X Plan (Lung Foundation Australia): ICS combinations benefit patients with frequent exacerbations or raised eosinophil counts.
• Recent studies suggest fluticasone furoate (Avamys®) provides effective 24-hour symptom control with once-daily use for allergic rhinitis (Australian Prescriber 2023).
• New inhaler designs have improved ease of use and dose tracking. Electronic reminders and apps have been shown to boost adherence in Australians (Asthma Australia, 2023–2024).
• Literature (BMJ, ERJ 2023–2024) confirms low systemic absorption and a favourable safety profile at standard doses.

Refer to sources such as Therapeutic Goods Administration, PBS, and Asthma Australia for detailed updates.

Availability and Delivery in Australia

Fluticasone products are widely available in local and online Australian pharmacies, subject to prescription validation. Delivery may vary by location, with most metropolitan areas receiving parcels within 2 business days.

FAQ – Common Patient Questions

1. How quickly does fluticasone start working?
   For asthma and allergies, you may notice symptom improvement within 24–72 hours, but full benefit can take up to 1–2 weeks of regular use.
2. Can I stop taking fluticasone when I feel better?
   No. It is important to use fluticasone as a regular preventer. Suddenly stopping may trigger worsening of symptoms. Discuss dose reduction or cessation with your GP.
3. Is it safe for long-term use?
   Yes, when prescribed and monitored by your healthcare team. Regular reviews reduce the risk of side effects and ensure the lowest effective dose.
4. What if I forget a dose?
   Take it as soon as you remember, unless it’s nearly time for your next dose. Don’t double up. Continue with your regular schedule.
5. Can fluticasone be used during pregnancy or breastfeeding?
   Generally considered safe at standard inhaled/nasal doses, but always seek your doctor’s advice if you are pregnant, planning pregnancy, or breastfeeding.